| 000 | 01237 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517011248.0 | ||
| 264 | 0 | _c20160621 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1776-260X | ||
| 024 | 7 |
_a10.1007/s11523-014-0352-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTabchi, S | |
| 245 | 0 | 0 |
_aRegorafenib: start low and go slow. _h[electronic resource] |
| 260 |
_bTargeted oncology _cSep 2015 |
||
| 300 |
_a445-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aGhosn, M | |
| 773 | 0 |
_tTargeted oncology _gvol. 10 _gno. 3 _gp. 445-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11523-014-0352-7 _zAvailable from publisher's website |
| 999 |
_c24495628 _d24495628 |
||